CanSino Biologics Inc
SSE:688185

Watchlist Manager
CanSino Biologics Inc Logo
CanSino Biologics Inc
SSE:688185
Watchlist
Price: 56.85 CNY 4.33% Market Closed
Market Cap: 9.2B CNY

Operating Margin
CanSino Biologics Inc

-41.2%
Current
-187%
Average
7.1%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-41.2%
=
Operating Profit
-348.5m
/
Revenue
846.3m

Operating Margin Across Competitors

Country Company Market Cap Operating
Margin
CN
CanSino Biologics Inc
SSE:688185
9.2B CNY
-41%
US
Eli Lilly and Co
NYSE:LLY
851.8B USD
38%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
3%
US
Johnson & Johnson
NYSE:JNJ
376B USD
26%
DK
Novo Nordisk A/S
CSE:NOVO B
1.9T DKK
48%
CH
Roche Holding AG
SIX:ROG
214.9B CHF
33%
CH
Novartis AG
SIX:NOVN
189.9B CHF
32%
UK
AstraZeneca PLC
LSE:AZN
166.3B GBP
23%
US
Merck & Co Inc
NYSE:MRK
215.4B USD
35%
IE
Endo International PLC
LSE:0Y5F
163.5B USD
11%
US
Pfizer Inc
NYSE:PFE
138.3B USD
25%

CanSino Biologics Inc
Glance View

Market Cap
9.2B CNY
Industry
Pharmaceuticals

CanSino Biologics Inc is a CN-based company operating in Pharmaceuticals industry. The company is headquartered in Tianjin, Tianjin and currently employs 1,946 full-time employees. The company went IPO on 2019-03-28. CanSino Biologics Inc is a clinical-stage vaccine company in China. The firm's products include Ad5-EBOV vaccine used for Ebola virus, MCV2 and MCV4 vaccines for meningococcus, PBPV vaccine used for pneumococcal and the recombinant novel coronavirus vaccine. Its products are mainly used in meningitis, diphtheria pertussis tetanus (DPT) and pneumonia.

Intrinsic Value
72.18 CNY
Undervaluation 21%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-41.2%
=
Operating Profit
-348.5m
/
Revenue
846.3m
What is the Operating Margin of CanSino Biologics Inc?

Based on CanSino Biologics Inc's most recent financial statements, the company has Operating Margin of -41.2%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 251,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.